cdmo.directory
← Home

CordenPharma

Global CDMO for peptides, lipids, oligonucleotides, injectables, and small molecules.

Listed on cdmo.directory

Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees.

Modalities

Development & manufacturing

Structured CDMO capabilities from verified public sources.

Synthetic chemistry infrastructure

Services

About this organization

Overview

CordenPharma is a globally-integrated CDMO founded in 2006, supporting pharmaceutical and biotechnology customers from early clinical-phase development through commercialization. The company operates 10 cGMP manufacturing facilities across Europe and North America with over 3000 employees.

Capabilities

CordenPharma provides complex modality support including:

  • Peptides — synthesis and manufacturing
  • Lipids & LNPs — lipid excipient development and manufacturing
  • Oligonucleotides — development and cGMP manufacturing
  • Injectables — formulation and fill-finish
  • Small Molecules — including highly potent APIs (HPAPI)
  • Oral Solid Dose (OSD) — development and manufacturing
  • Drug Products — complete formulation and manufacturing support
  • Packaging Services — secondary packaging and associated services

Organization

Capabilities are organized under six Technology Platforms, each led by a Platform Director. The company emphasizes scientific expertise, cutting-edge technologies, and partnership-driven outsourcing spanning the complete supply chain from development to commercialization.

Certifications

AuthorityIdentifierSource
cGMPcGMP certified facilitiesView
FDAcGMPView

Locations

  • Global Network

Submit a verified review for this organization.

Markdown mirror: /companies/cordenpharma.md